Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.
作者信息
Evens Andrew M, Brandt Justin S, Peer Cody J, Yin Tyler, Schaar Dale, Farooq Faheem, Mozarsky Brett, Figg William D, Sharon Elad
机构信息
Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Departments of Medicine and Maternal Fetal Medicine, Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.
出版信息
Am J Hematol. 2022 Jun 1;97(6):833-838. doi: 10.1002/ajh.26527. Epub 2022 Mar 21.
Abstract
摘要
相似文献
1
Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.孕期使用检查点抑制剂免疫疗法治疗复发难治性霍奇金淋巴瘤。
Am J Hematol. 2022 Jun 1;97(6):833-838. doi: 10.1002/ajh.26527. Epub 2022 Mar 21.
2
Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.用于霍奇金淋巴瘤和非霍奇金淋巴瘤的检查点抑制剂及其他免疫疗法。
Curr Treat Options Oncol. 2016 Jun;17(6):31. doi: 10.1007/s11864-016-0401-9.
3
New approaches to managing relapsed/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyond.管理复发/难治性霍奇金淋巴瘤的新方法：检查点抑制剂及其他方法的作用。
Expert Rev Hematol. 2021 Aug;14(8):741-750. doi: 10.1080/17474086.2021.1962278. Epub 2021 Aug 13.
4
Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma.复发或难治性霍奇金淋巴瘤的治疗进展。
Curr Oncol Rep. 2020 Jan 24;22(1):6. doi: 10.1007/s11912-020-0866-3.
5
Novel agents in classical Hodgkin lymphoma.经典型霍奇金淋巴瘤的新型治疗药物
Leuk Lymphoma. 2017 Oct;58(10):2275-2286. doi: 10.1080/10428194.2017.1300898. Epub 2017 Mar 20.
6
Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?新药在复发/难治性霍奇金淋巴瘤治疗中处于什么地位？
Curr Hematol Malig Rep. 2017 Jun;12(3):227-233. doi: 10.1007/s11899-017-0384-z.
7
Pregnancy outcome after early exposure to nivolumab, a PD-1 checkpoint inhibitor for relapsed Hodgkin's lymphoma.早期接触纳武单抗（一种用于复发霍奇金淋巴瘤的PD-1检查点抑制剂）后的妊娠结局。
Clin Toxicol (Phila). 2022 Apr;60(4):535-536. doi: 10.1080/15563650.2021.1981361. Epub 2021 Sep 21.
8
Antibody based therapies in Hodgkin lymphoma.抗体药物在霍奇金淋巴瘤中的应用。
Cancer Treat Rev. 2024 Jan;122:102647. doi: 10.1016/j.ctrv.2023.102647. Epub 2023 Oct 28.
9
Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?霍奇金淋巴瘤中的检查点抑制：把最好的留到最后？
Oncology (Williston Park). 2016 Oct 15;30(10):914-20.
10
Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases.放疗联合纳武单抗治疗复发/难治性经典型霍奇金淋巴瘤：附两例病例
Cancer Radiother. 2019 Jun;23(3):232-239. doi: 10.1016/j.canrad.2018.12.005. Epub 2019 May 27.
引用本文的文献
1
Caring for Pregnant Patients with Cancer: A Framework for Ethical and Patient-Centred Care.关爱患癌孕妇：以伦理和患者为中心的护理框架。
Cancers (Basel). 2024 Jan 21;16(2):455. doi: 10.3390/cancers16020455.
2
An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy.一项关于妊娠期间发生的复发/难治性淋巴瘤的国际真实世界分析。
Blood Adv. 2023 Sep 26;7(18):5480-5484. doi: 10.1182/bloodadvances.2023010090.
3
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer.病例报告：一名患有晚期表皮生长因子受体（EGFR）突变型非小细胞肺癌的女性在孕期使用奥希替尼。
Front Oncol. 2023 Mar 24;13:1108124. doi: 10.3389/fonc.2023.1108124. eCollection 2023.
本文引用的文献
1
Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review.检查点抑制剂、生育力、妊娠和性生活：系统评价。
ESMO Open. 2021 Oct;6(5):100276. doi: 10.1016/j.esmoop.2021.100276. Epub 2021 Sep 28.
2
Immune checkpoint inhibitor administration during pregnancy: a case series.孕期免疫检查点抑制剂治疗：病例系列研究。
ESMO Open. 2021 Oct;6(5):100262. doi: 10.1016/j.esmoop.2021.100262. Epub 2021 Sep 3.
3
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.癌症免疫治疗期间妊娠结局：美国国立癌症研究所临床试验分析。
Oncologist. 2021 Oct;26(10):e1883-e1886. doi: 10.1002/onco.13941. Epub 2021 Sep 20.
4
Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗背景下的免疫相关血液学不良事件。
Am J Hematol. 2021 Oct 1;96(10):E362-E367. doi: 10.1002/ajh.26273. Epub 2021 Jul 2.
5
Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches.妊娠期淋巴瘤：当前的诊断和治疗方法。
Curr Oncol Rep. 2020 Aug 17;22(11):113. doi: 10.1007/s11912-020-00972-1.
6
How I treat lymphoma in pregnancy.我在妊娠期治疗淋巴瘤的方法。
Blood. 2020 Nov 5;136(19):2118-2124. doi: 10.1182/blood.2019000961.
7
Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.霍奇金淋巴瘤：2020 年诊断、风险分层和治疗的更新。
Am J Hematol. 2020 Aug;95(8):978-989. doi: 10.1002/ajh.25856. Epub 2020 Jun 8.
8
Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition.转移性黑色素瘤患者在接受 CTLA-4 和 PD-1 检查点抑制治疗时出现妊娠和活胎双胎。
Melanoma Res. 2020 Aug;30(4):423-425. doi: 10.1097/CMR.0000000000000657.
9
Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester: case report and review of the literature.在孕早期接受纳武利尤单抗治疗的黑色素瘤患者中成功妊娠并母婴结局良好：病例报告及文献复习。
Melanoma Res. 2019 Jun;29(3):333-337. doi: 10.1097/CMR.0000000000000586.
10
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.孕期IV期黑色素瘤患者使用伊匹木单抗联合纳武单抗进行免疫治疗。
Eur J Cancer. 2018 Nov;104:239-242. doi: 10.1016/j.ejca.2018.09.008. Epub 2018 Oct 25.
Zotero 插件